Schmidt D - Search Results

1

Comprehensive analysis of the transcriptional profile of the Mediator complex across human cancer types.

Syring I, Klümper N, Offermann A, Braun M, Deng M, Boehm D, Queisser A, von Mässenhausen A, Brägelmann J, Vogel W, Schmidt D, Majores M, Schindler A, Kristiansen G, Müller SC, Ellinger J, Adler D, Perner S. Syring I, et al. Among authors: schmidt d. Oncotarget. 2016 Apr 26;7(17):23043-23055. doi: 10.18632/oncotarget.8469. Oncotarget. 2016. PMID: 27050271 Free PMC article.

2

Limitations of detection of bone-marrow micrometastasis in prostate carcinoma patients by CK18/PSA immunocytochemistry and PSA RT-PCR.

Albers P, Ko Y, Wardelmann E, Schmidt D, Adam M, Vetter H, Müller SC. Albers P, et al. Among authors: schmidt d. Anticancer Res. 2000 May-Jun;20(3B):2107-11. Anticancer Res. 2000. PMID: 10928161

3

Soluble Fas and Fas-ligand in bladder cancer in vitro and in vivo.

Perabo FG, Mattes RH, Wirger A, Steiner G, Kamp S, Schmidt D, Pegelow K, von Ruecker A, Müller SC. Perabo FG, et al. Among authors: schmidt d. Urol Oncol. 2001 Jul;6(4):163-169. doi: 10.1016/s1078-1439(00)00130-7. Urol Oncol. 2001. PMID: 11418323

4

PIAS/SUMO: new partners in transcriptional regulation.

Schmidt D, Müller S. Schmidt D, et al. Cell Mol Life Sci. 2003 Dec;60(12):2561-74. doi: 10.1007/s00018-003-3129-1. Cell Mol Life Sci. 2003. PMID: 14685683 Free PMC article. Review.

5

Preclinical evaluation of gemcitabine/paclitaxel-interactions in human bladder cancer lines.

Perabo FG, Lindner H, Schmidt D, Huebner D, Blatter J, Fimmers R, Müller SC, Albers P. Perabo FG, et al. Among authors: schmidt d. Anticancer Res. 2003 Nov-Dec;23(6C):4805-14. Anticancer Res. 2003. PMID: 14981929

6

Carboxyamido-triazole (CAI), a signal transduction inhibitor induces growth inhibition and apoptosis in bladder cancer cells by modulation of Bcl-2.

Perabo FG, Wirger A, Kamp S, Lindner H, Schmidt DH, Müller SC, Kohn EC. Perabo FG, et al. Anticancer Res. 2004 Sep-Oct;24(5A):2869-77. Anticancer Res. 2004. PMID: 15517890 Free article.

7

GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age?

Bastian PJ, Ellinger J, Schmidt D, Wernert N, Wellmann A, Müller SC, von Rücker A. Bastian PJ, et al. Among authors: schmidt d. Eur J Med Res. 2004 Nov 29;9(11):523-7. Eur J Med Res. 2004. PMID: 15649863

8

Carboxyamido-triazole (CAI) reverses the balance between proliferation and apoptosis in a rat bladder cancer model.

Perabo FG, Demant AW, Wirger A, Schmidt DH, Sitia M, Wardelmann E, Müller SC, Kohn EC. Perabo FG, et al. Anticancer Res. 2005 Mar-Apr;25(2A):725-9. Anticancer Res. 2005. PMID: 15868902 Free article.

9

Hyperoxia-induced improvement of the in vitro response to gemcitabine in transitional cell carcinoma.

Fechner G, Dederichs F, Schmidt D, Müller S, Vaupel P, Albers P. Fechner G, et al. Among authors: schmidt d. Anticancer Res. 2005 Sep-Oct;25(5):3413-8. Anticancer Res. 2005. PMID: 16101157 Free article.

10

Reducing recurrence and costs in superficial bladder cancer: preclinical evaluation of osmotic cytolysis by distilled water vs. mitomycin.

Fechner G, Pocha K, Schmidt D, Müller SC. Fechner G, et al. Among authors: schmidt d. Int J Clin Pract. 2006 Oct;60(10):1178-80. doi: 10.1111/j.1742-1241.2006.00847.x. Int J Clin Pract. 2006. PMID: 16669821

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,095 results

Search Page